Company Financials

YiChang HEC ChangJiang Pharmaceutical Co. Ltd Financials

Hong Kong dollar

business YiChang HEC ChangJiang Pharmaceutical Co. Ltd Company Profile

Main Stock Listing

HKEX: 1558

Market Capitalization HK$12.81 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 5, 2025

Trailing PE 24.27
Forward PE 5.56
Price to Sales TTM HK$3.44
Price to Book MRQ HK$1.51
Enterprise to Revenue 3.73
Enterprise to EBITDA 13.19

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin 12.96%
Operating Margin -11.76%
Return on Assets TTM 3.32%
Return on Equity TTM 5.87%

Income Statement

Revenue TTM HK$4,077,914,666
Revenue per Share TTM HK$4.23
Quarterly Revenue Growth -58.90%
Gross Profit TTM HK$3,059,772,898
EBITDA HK$1,259,254,000
Net Income to Common TTM HK$528,617,911
Diluted EPS TTM HK$0.60
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ HK$1,541,480,281
Total Cash per Share MRQ HK$1.60
Total Debt MRQ HK$
Total Debt to Equity MRQ 26.27
Current Ratio MRQ 1.77
Book Value per Share MRQ HK$9.67

Cash Flow

Operating Cash Flow TTM HK$97,921,651
Levered Free Cash Flow TTM HK$-102,188,704

1558 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding 879,967,700
Float Shares 405,321,922
Avg 10 Volume 7,449,420
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 38.00%
% Held by Institutions 8.56%

Stock Price Summary

Beta 0.04
Fifty Two Week Low HK$7.92
Fifty Two Week High HK$15.54
Fifty Two Week Change 39.03%
Day 50 MA HK$13.66
Day 200 MA HK$10.51

Dividends and Splits

Forward Annual Dividend Rate HK$0.23
Forward Annual Dividend Yield 1.57%
Trailing Annual Dividend Rate HK$0.28
Trailing Annual Dividend Yield 1.91%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2025-07-31
Last Split Factor
Last Split Date 2020-06-09